15 results on '"Ranelletti, FO"'
Search Results
2. EFFECT OF SYNTHETIC AND NATURALLY OCCURRING CHALCONES ON OVARIAN CANCER CELL GROWTH: STRUCTURE, ACTIVITY, RELATIONSHIP
3. Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS): correlation with growth inhibitory activity
4. Reply to the letter to the editors by Sakar MA: Quercetin not only inhibits the P-glycoprotein efflux activity but also inhibits CYP3A isozymes
5. Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast cancer cell line: P-glycoprotein as a possible target
6. Quercetin enhances trasforming growth factor B1 secretin from human ovarian cancer cells
7. Quercetin induces type II estrogen binding sites in estrogen receptor negative (MDA-MB231) and estrogen receptor positive (MCF-7) human breast cancer cell lines
8. Type II estrogen binding sites in human ovarian cancer: correlation with estrogen (ER), progesterone (PR), and epidermal growth factor receptor (EGFR)
9. Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumors
10. Synergistic antiproliferative activity of quercetin and cis- diamminedichloroplatinum on ovarian cancer cell growth
11. Morphological changes induced by epidermal growth factor and estradiol in CG-5 human breast cancer cellG line: a scanning electron microscopy study
12. Type II estrogen binding sites in a human lymphoblastoid cell line and growth inhibitory effect of estrogen, antiestrogen and bioflavonoids
13. Type II oestrogen binding sites in acute lymphoid and non- lymphoid leukaemias. Growth inhibitory effects of oestrogens and flavonoids
14. Type II estrogen binding sites and 17beta-hydroxysteroid dehydrogenase activity in human peripheral blood mononuclear cells
15. Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.